Frankie Montas

Mets Reinstate Frankie Montas, Transfer Jesse Winker To 60-Day IL

By Darragh McDonald | June 24, 2025 at 12:59pm CDT

The Mets announced that right-hander Frankie Montas has been reinstated from the 60-day injured list. Right-hander Chris Devenski was optioned to Triple-A Syracuse as the corresponding active roster move. He has enough service time where he can’t be optioned without his consent, so he has presumably agreed to be sent down. To open a 40-man spot for Montas, outfielder/designated hitter Jesse Winker has been transferred to the 60-day IL.

Montas, 32, will be making his debut as a Met when he starts tonight’s game. At the moment, it’s difficult to guess what sort of quality of performance he’ll be able to provide. He was diagnosed with a lat strain back in mid-February. He started a rehab assignment in late May but hasn’t looked sharp, allowing 25 earned runs in 18 2/3 innings over six minor league starts.

Teams generally care more about health than results on a rehab assignment but a 12.05 earned run average is going to cause some concern. It would be one thing if Montas started rough and had been getting sharper but that hasn’t been the case. He surrendered five earned runs in five innings in his most recent outing, with just two strikeouts. The prior outing had seen him allow eight earned runs without getting out of the second inning.

Even before this year, there were question marks with Montas. He had missed almost all of 2023 due to shoulder surgery. Back on the mound in 2024, his 4.84 ERA wasn’t strong. The Mets seemed to be banking on his late-season strikeout surge. He had struck out just 19% of batters faced with the Reds but then 28.7% of opponents following a trade to the Brewers. He then headed into free agency and secured a two-year, $34MM deal from the Mets, with equal salaries of $17MM and an opt-out halfway through.

That was a notable investment in a pitcher who hadn’t been at his best in a few years. The Mets are also paying a 110% tax on spending beyond the top competitive balance tax threshold this year, making it an even more significant expenditure which they have yet to receive any return on.

Despite that cash outlay, the righty’s recent struggles on his rehab assignment almost pushed him to the bullpen. However, the club’s rotation picture changed quickly in recent weeks. Not too long ago, it seemed the club had so much rotation depth that a Paul Blackburn trade was reportedly considered. But then both Kodai Senga and Tylor Megill hit the injured list in the span of a few days, opening rotation space for both Blackburn and Montas alongside David Peterson, Clay Holmes and Griffin Canning.

If everyone is healthy, another squeeze could be just over the horizon. Sean Manaea is also on the IL and just a bit behind Montas in his rehab process. He recently made his fourth rehab appearance, getting to 62 pitches over 5 1/3 innings. Montas is getting a rotation spot for now due to the club’s need and the fact that his 30-day rehab window was closing but there will be pressure on him to perform in order to keep that spot.

As for Winker, he landed on the IL on May 5th due to a right oblique strain. His 60-day count is retroactive to that initial IL placement, so he’ll be eligible for reinstatement in early July. He was initially given a recovery timeline of six to eight weeks but the Mets recently said that he is still multiple weeks away from starting a rehab assignment.

Photo courtesy of Sam Navarro, Imagn Images

Latest On Mets’ Rotation Plans

By Anthony Franco | June 19, 2025 at 11:29pm CDT

The Mets’ season-worst losing streak stretched to six games with tonight’s 7-1 defeat in Atlanta. Clay Holmes was unable to escape the fifth inning, and the Mets turned to righty Justin Hagenman to work the final 2 2/3 frames in mop-up fashion. Hagenman had been the likeliest choice to start tomorrow’s series opener against the Phillies, necessitating a change of plans.

As first reported by Anthony DiComo of MLB.com, New York will now turn to Blade Tidwell opposite Zack Wheeler. They’ll need to recall the 6’4″ righty tomorrow afternoon. It’ll be the second MLB appearance of his career. The Mets called up the former second-round pick for a spot start against the Cardinals on May 4. He gave up six runs in 3 2/3 innings to take the loss and was optioned back to Triple-A Syracuse the next day. Tidwell, one of the better pitching prospects in the organization, has worked 62 1/3 innings over 13 Triple-A appearances this season. He carries a 4.76 ERA but has punched out nearly 28% of opponents against a 9.5% walk rate.

This is likely to again be a one-off appearance. Frankie Montas has been on a minor league rehab assignment since May 24. Pitchers can spend up to 30 days on a rehab stint before they need to be activated (unless they suffer an injury setback). Montas’ rehab window closes on Monday, at which point the Mets need to put him on the MLB roster.

Manager Carlos Mendoza confirmed before Thursday’s game that Montas will be in the rotation (link via Tim Britton of The Athletic). That wouldn’t have seemed in doubt at the beginning of the rehab stint. The Mets signed Montas to a two-year, $34MM free agent deal. He would’ve opened the season in the middle of the rotation had he not suffered a significant lat strain early in Spring Training. The results on his rehab stint have been dreadful, however.

Montas has allowed more than 12 earned runs per nine innings over six rehab starts: two in High-A, four in Triple-A. Teams generally don’t place much stock in a player’s stats while he’s rehabbing. The primary focus is on getting healthy. Yet Montas’ struggles have been so significant that the Mets must be at least a little concerned. He has allowed more than a run per inning in three of his four Triple-A outings. Opponents have combined for a staggering eight home runs in 14 1/3 innings. He gave up five runs on seven hits (including one homer) while striking out only two of 23 batters faced against Miami’s top farm team on Wednesday.

The results certainly don’t suggest he’s ready to face MLB hitters, but the Mets are out of time on the rehab stint. There was some thought that they could activate Montas as a reliever, at least allowing Mendoza to deploy him in low-leverage situations as he tries to iron out his mechanics. That might have been the plan had they not lost Kodai Senga and Tylor Megill to the injured list within the past week. “Look, we need starters here,” Mendoza acknowledged to reporters. “We signed him to be a starter for this team, and we’re going to give him a chance.” That likely positions Montas to make his team debut early next week when the Mets welcome the Braves to Citi Field.

It was just eight days ago that the Mets were reportedly receiving interest in Paul Blackburn because it was unclear if they’d have room for him as a starting pitcher. New York had pushed their lead in the NL East to a season-best 5.5 games that same afternoon. Now, they’re tied with the Phillies as they head into this weekend’s series at Citizens Bank Park. Blackburn looks like a short-term rotation fixture behind Holmes, David Peterson and Griffin Canning. Montas will slot into the fifth spot after getting bombed by minor league lineups.

While things have gone downhill quickly, there’s more cause for optimism in the medium term. Sean Manaea, who has been out all season due to a Spring Training oblique strain, has been on a rehab assignment since June 6. His numbers are also poor, but that’s not as concerning when a pitcher is shaking off the rust very early in a rehab stint. He’s around two weeks away from an MLB return. Senga has a low-grade hamstring strain. He could resume throwing by the end of the month and return in mid-July if all goes well. The news on Megill is less encouraging, as he’ll miss at least 4-5 weeks with an elbow sprain.

The front office will have a little more than five weeks to see how their injured pitchers progress and gauge what they can get out of Montas before deciding on trade deadline priorities. Jon Heyman of The New York Post wrote this evening that they’re likely to be involved in the rotation market once July 31 approaches. That’s true of almost all contending teams, of course. The next month will go a long way to determining their sense of urgency to add a starting pitcher.

Mets Place Tylor Megill On IL With Elbow Sprain

By Darragh McDonald | June 17, 2025 at 4:25pm CDT

4:25pm: Manager Carlos Mendoza tells Anthony DiComo of MLB.com that the best-case scenario for Megill is a return in four to five weeks. The club plans to have a spot starter on Friday and Montas perhaps joining the rotation after that, depending on how his next rehab outing goes.

3:05pm: The Mets announced that right-hander Tylor Megill has been placed on the 15-day injured list, retroactive to June 15th, due to a right elbow sprain. Fellow righty Justin Garza has been recalled in a corresponding move.

Megill told members of the media, including Laura Albanese of Newsday, that he just has inflammation and no ligament damage. That doesn’t fully align with the official announcement, as a sprain involves some degree of stretching or tearing, by definition. Regardless, it seems like Megill doesn’t expect a lengthy absence. He says he’ll be shut down for seven to ten days before being reevaluated.

Assuming that ends up being the case, that would obviously be good news, as he was on the road to having a personal-best season here in 2025. He has largely been a serviceable back-end starter for the Mets, with a 4.56 earned run average coming into the campaign. This year, prior to this IL stint, he has made 14 starts with a 3.95 ERA. His 10.8% walk rate would be higher than any other season in his career, but barely. Meanwhile, his 29.2% strikeout rate is quite strong and is way ahead of his 24.3% career rate.

He qualified for arbitration for the first time in the most recent offseason and is making $1.975MM this year. He will be due a raise this coming winter but a notable absence would obviously cut into his earning power, so he’ll naturally be hoping to bounce back quickly.

For the Mets, this is the latest domino to fall in a quickly-changing rotation picture. Last week, it was reported that the Mets were getting calls on righty Paul Blackburn, on account of a fairly crowded starting mix. But within minutes of that report coming out, Kodai Senga suffered an injury and was later placed on the 15-day IL due a strained hamstring.

In the modern game, any pitching surplus is a temporary thing, which is clearly demonstrated here. The Mets are now down to David Peterson, Clay Holmes, Griffin Canning and Blackburn as their rotation options. Frankie Montas has been on a path to join that group but his rehab assignment has been shaky. He has been on the IL all year due to a lat strain and has a 13.17 ERA over his five rehab outings. In the most recent one, he allowed eight earned runs without getting out of the second inning.

Due to those struggles, there’s been some speculation that the Mets might push Montas into the bullpen, though the Megill injury might make him more needed in the rotation. On the other hand, Sean Manaea is also on a rehab assignment and should be in the mix soon as well. His rehab assignment also hasn’t gone super well so far in terms of results, but he’s earlier in the process, having only made three appearances thus far.

Time will tell how the Mets play it. Peterson, Blackburn and Holmes are the scheduled starters for the next three games. Megill was originally scheduled to get the ball on Friday. Canning could perhaps start that one instead but they would still need to someone for Saturday’s game. Guys like Blade Tidwell, Justin Hagenman and Brandon Waddell are on the 40-man roster and could factor in at some point, at least until the Mets get some guys back from the IL.

It will be a situation worth monitoring for other clubs, especially with the trade deadline just over a month away. As recently as a week ago, the Mets looked to have enough starting options where selling was a possibility but perhaps buying will become a consideration.

Photo courtesy of Gary A. Vasquez, Imagn Images

Mets Notes: Siri, Winker, Senga, Montas, Raley

By Mark Polishuk | June 14, 2025 at 8:29am CDT

Mets president of baseball operations David Stearns and manager Carlos Mendoza each provided several injury updates when speaking with reporters (including Newsday’s Laura Albanese, The Athletic’s Tim Britton, and the New York Post’s Mike Puma) on Friday. The most unwelcome bit of news concerned Jose Siri, whose recovery from a left tibia fracture will be delayed since tests showed the tibia hadn’t healed as well as expected over two months since the initial injury.

Siri last played on April 12, when he fouled a ball off his left leg during his first plate appearance in the Mets’ 3-1 loss to the Athletics. The initial recovery timeline was set at 8-10 weeks, though in the wake of this latest setback, Siri will now be shut down from baseball activities for a few more weeks until he undergoes a fresh round of imaging tests.

Even if those tests reveal better results, Siri will need to ramp his rehab back up and play in multiple minor league games, so it may be optimistic to expect Siri back on New York’s big league roster before July is over. It’s a frustrating setback for Siri, who seemed to be making progress by taking part in live batting practice sessions and doing some running drills in recent weeks. Instead, it now looks like he’ll miss over half of the season on the injured list, leaving the Mets without a key member of their outfield.

Acquired from the Rays in a trade last November, Siri was meant to add some power and (most pressingly) defensive stability to the Amazins’ center field mix. His absence has made Tyrone Taylor more or less the everyday center fielder, and while Taylor has held his own with the glove, he is hitting only .234/.300/.332 over 205 plate appearances. The left-handed hitting Jeff McNeil has been spelling Taylor in center field when McNeil isn’t at second base, and Jose Azocar, Brandon Nimmo, and Luisangel Acuna have made a few cameos in center when the situation has warranted.

It was already expected that the Mets would be looking for some outfield help at the trade deadline, and the possibility that Siri might not even be back by July 31 only underlines the outfield as a target area. Perhaps if the Mets are okay with the Taylor/McNeil platoon in center field, the club might just look to add a bat in general to help out in the infield or in the DH position. Designated hitter Jesse Winker is recovering from a Grade 2 oblique strain that has kept him out since early May, and Stearns said that Winker will still need multiple weeks before a minor league rehab assignment is considered.

Kodai Senga’s hamstring strain created a big hole in New York’s rotation this week, though Mendoza said tests revealed that Senga had only a Grade 1 strain, or the least severe variety. The current plan is for Senga to be shut down for two weeks and then the club will explore plans for a throwing progression and a minor league rehab assignment. Given the timing, it seems possible Senga might be able to pitch again before the All-Star break, but in all likelihood the Mets will play it safe with their ace and hold him out through the break to give him a few more days of rest.

The Mets’ rotation has been plagued by injuries ever since Spring Training, yet the staff has greatly exceeded expectations by still leading all of baseball with a 2.78 rotation ERA. Senga’s 1.47 ERA over 73 2/3 innings has been a big part of that success, as the right-hander has returned in top form after missing virtually all of the 2024 season.

Paul Blackburn will move from a long relief/swingman role into the rotation to fill in for Senga, while Britton suggests that Frankie Montas might move into the bullpen in Blackburn’s role (rather than into a starting job) when Montas is activated from the 60-day injured list. After missing the entire season due to a lat strain, Montas has made five minor league rehab starts, and June 22 will mark the end of the allotted 30 days for Montas’ rehab assignment.

While in-game results are usually less important than fitness and mechanics during these rehab outings, Montas’ 13.17 ERA over 13 2/3 innings with high-A Brooklyn and Triple-A Syracuse is hard to ignore, as the veteran righty is clearly still not on track. Stearns said that Montas will make one more start in the minors, and that Montas “is still searching a little bit” after such a long layoff.

“Physically, we are trending in the right direction and now it’s just getting him back into the rhythm,” Stearns said. “This is very similar to a Spring Training ramp up where you try not to focus on results too much early and then as you get a little bit later in the ramp up you want to start seeing outs. That is where Frankie is right now.”

In even longer-term injury news, Brooks Raley could be starting a rehab assignment within the next week. Raley underwent a Tommy John surgery in May 2024, and with the knowledge that he’d miss most of the 2025 season, the Mets inked the veteran reliever to a one-year free agent deal that guarantees Raley $1.85MM ($1.5MM in 2025 salary, and a $300K buyout on a $4.75MM club option for 2026).

Several other performance bonuses are available both this season and next depending on how many appearances Raley can make, though the first order of business is simply getting the southpaw back in action. Britton notes that Raley will likely need the full 30-day rehab window in order to get back into game shape, so if all goes well, Raley could be an option for the Mets’ bullpen before the end of July.

Mets Receiving Trade Interest In Paul Blackburn

By Steve Adams | June 12, 2025 at 2:01pm CDT

With several teams around the league straining to find rotation help, the Mets have been receiving early interest in righty Paul Blackburn, reports Joel Sherman of the New York Post. There’s no indication a trade is close, but there’s good reason to think the Mets might be amenable to an earlier-than-usual trade involving the veteran righty.

The Mets are currently six-deep in starters, with Blackburn the ostensible odd man out. Kodai Senga, David Peterson, Clay Holmes, Griffin Canning and Tylor Megill have all pitched well this season. All five have started at least a dozen games, and none has an ERA higher than Megill’s 3.76. Blacknburn’s most recent outing came in long relief, although Sherman notes that he could get a spot start or two with an upcoming run of 13 games in 13 days.

That said, both Frankie Montas and Sean Manaea are out on minor league rehab stints. The former has made four starts and built up to 76 pitches, while the latter tossed 46 pitches over 2 2/3 innings in his second rehab start two days ago. As such, Montas is the closer of the pair to returning and could even be ready to go next week. He’s slated to make his fifth rehab appearance tomorrow, but there’s still enough time left on his rehab clock that he could make two more starts if the team sees fit. Manaea’s rehab window extends into early July, as he only began his assignment on June 6.

One way or another, within the next two to three weeks, the Mets could find themselves with as many as seven or eight healthy rotation options. All are largely established as big league starting pitchers as well, so it’s not as though they have a young, optional arm to send back to Syracuse for a bit.

Peterson can technically still be optioned, but only for another five days. He’s on the cusp of reaching five years of MLB service time, at which point he’d have to consent to being sent down. It’s a moot point, though, given how well he’s pitching. Megill also has an option, but he’s bounced back from a run of shaky starts in early-to-mid May by rattling off 21 1/3 innings with a 3.80 ERA and 28-to-9 K/BB ratio. His season-long numbers are strong, and a depth-focused Mets front office, helmed by president David Stearns, surely doesn’t want to burn Megill’s final option year at a time when he’s pitching well.

One potential wrinkle that could impact the Mets’ rotation depth unfolded as I was writing that last paragraph: Senga exited today’s game against the Nationals with an injury. The right-hander covered first base on a grounder to the right side of the infield, made a leaping catch to corral the throw, and grabbed at his leg after coming down on the bag (video link via SNY). Senga eventually walked off the field under his own power, but he was down on the field for a couple minutes with the Mets’ training staff.

A lot will hinge on whether Senga is forced to skip a start or head to the injured list. There’s no way to know for the time being. He’s surely just in the very initial stages of evaluation. That situation will be worth watching with a close eye, but so long as he avoids a lengthy trip to the IL, that same scenario of six to eight generally established big league starters vying for five rotation spots will loom as a possibility. The Mets could move to a six-man rotation, of course, though Sherman notes that they prefer not to play one reliever short, as they’d be required to do by rolling out a permanent six-man staff.

If the Mets do end up giving serious thought to trading Blackburn, there’ll be no shortage of interested teams. He’s hardly a front-of-the-rotation piece, but the 31-year-old righty carries a 4.39 ERA, 20.1% strikeout rate and 7.5% walk rate over his past 299 1/3 major league innings. He’s pitched in 58 games over that stretch, with all but two of them coming out of the rotation.

Blackburn is in his final season of club control. He’s being paid $4.05MM this year, with about $2.35MM of that sum yet to be paid out. He’s a free agent at the end of the season, so the Mets probably won’t get a particularly large return for him, but they could get a nominal prospect or perhaps a lower-end reliever with more team control. On top of that, trading Blackburn would actually save the Mets around $4.94MM, given that they’re deep in the top bracket of luxury tax penalization and thus subject to a 110% tax on every dollar over the top threshold.

NL East Notes: Montas, Blackburn, Manaea, Nola, Finnegan

By Mark Polishuk | May 25, 2025 at 8:29am CDT

Frankie Montas saw his first proper game action of the 2025 season on Saturday, when the right-hander tossed 37 pitches over 1 1/3 innings for high-A Brooklyn in the first game of a minor league rehab assignment. Montas signed a two-year, $34MM free agent deal with the Mets this past winter, but was immediately sidelined at the start of Spring Training by a significant lat strain. Saturday’s game officially started the 30-day clock on Montas’ rehab assignment, and he’ll naturally need to further build up his arm strength over multiple outings before he is ready to be activated from the 60-day injured list.

Paul Blackburn should beat Montas back to the active roster, as MLB.com’s Jeffrey Lutz writes that the plan is for Blackburn to make his seventh and final minor league rehab outing before joining the Mets at some point in June. Blackburn has missed the entire big league season due to right knee inflammation, while Sean Manaea has also yet to pitch due to an oblique strain. Manaea is throwing off a mound, and Jon Heyman of the New York Post writes that Manaea’s projected timeline is about two weeks behind Montas. Despite all of these pitching injuries, even the makeshift version of the Mets’ rotation has posted tremendous results this season, giving the club a potential arms surplus to address if and when everyone is healthy.

Mets Select Genesis Cabrera, Ty Adcock

By Steve Adams and Darragh McDonald | May 1, 2025 at 10:30am CDT

10:30am: The Mets announced that Minter and right-hander Frankie Montas have been transferred from the 15-day IL to the 60-day IL, which opens a pair of 40-man spots for Cabrera and Adcock. Montas, like Minter, is dealing with a lat strain. His occurred during spring training, however, and the team’s hope is that he can be ready to join the rotation early this summer. He’s already spent 35 days on the IL, however, and the move to the 60-day list does not reset that clock.

9:20am: The Mets announced Thursday that they’ve selected the contracts of left-handed reliever Genesis Cabrera and right-handed reliever Ty Adcock. Lefty Brandon Waddell and righty Chris Devenski were optioned to Triple-A Syracuse to clear spots on the active roster. The Mets haven’t announced corresponding 40-man moves yet but noted in their announcement that those transactions will be revealed later today. A.J. Minter and Danny Young are both facing lengthy injury absences, so they may be moved to the 60-day injured list to open those 40-man spots. Devenski has presumably agreed to be optioned since he has at least five years of major league service time. Such players can’t be optioned to the minors without their consent.

The southpaw contingent of the Mets’ bullpen has been wiped out in a span of a few days. Up until recently, they had both Minter and Young available. Minter had a 1.64 earned run average through his first 13 appearances. Young’s 4.32 ERA through 10 outings was less impressive but he had a huge 35.1% strikeout rate and 63.2% ground ball rate, as well as a solid 8.1% walk rate. His .450 batting average on balls in play and 61.5% strand rate were both on the unlucky side, which is why his 1.40 FIP and 1.75 SIERA pointed to better results going forward.

That meant manager Carlos Mendoza had a couple of strong options from the left side but that has quickly changed. Minter landed on the 15-day IL on the weekend due to a lat strain and season-ending surgery is a possibility. Young hit the 15-day IL yesterday due to an elbow sprain and he may require Tommy John surgery. So not only are the Mets going to be without Minter and Young in the short term, but maybe for the entire season.

That is surely what has brought Cabrera up to the big leagues today. The 28-year-old signed a minor league deal with the Mets in the offseason and has been pitching for their Triple-A club. He has tossed eight innings over seven appearances for Syracuse. The 7.88 ERA in that time isn’t pretty but it’s a small sample and with a miniscule 34.9% strand rate. He has struck out 35.3% of batters faced and kept balls in play on the ground at a 50% clip, though also with a 14.7% walk rate.

Lack of control is the main knock on Cabrera. He has 275 2/3 innings of major league experience with the Cardinals and Blue Jays, having walked 11.4% of batters faced in that time. He’s been able to work around that at times with strikeouts, though he’s been inconsistent in that regard.

He had a 26% strikeout rate with the Cards in 2021, allowing him to post a 3.73 ERA. But he only punched out 16% of batters in 2022, which helped bump his ERA to 4.63. He corrected a bit in 2023 with a 24.3% strikeout rate and 4.04 ERA. It was a mixed bag last year, as his ERA dropped to 3.59 but mostly via luck. His 18.5% strikeout rate and 10% walk were both subpar figures, but he had a 78.8% strand rate. His 5.13 FIP and 4.58 SIERA both point to the ERA being a mirage.

The Jays seemingly didn’t have faith in him keeping runs off the board at that pace. They could have retained him via arbitration, with MLBTR contributor Matt Swartz projecting a modest $2.5MM salary for this year, but they cut him from the roster instead. That is what led to him landing with the Mets on a minor league deal. The injuries have created a path for him to get back to the majors. He will provide the Mets with one lefty reliever for now and the club will see which version of Cabrera they get.

The club also just needs arms generally, regardless of handedness. They are in the middle of a span where they play 13 straight games. Waddell and Devenski were just called up and combined to cover 6 1/3 innings in yesterday’s game, the former logging 4 1/3 and the latter going for two frames.

They have been swapped out for both Cabrera and Adcock. The 28-year-old Adcock has a fairly limited major league track record, with 20 innings tossed between the 2023 Mariners and 2024 Mets. He has a 5.85 ERA in that time. He has a much better 1.29 ERA in seven innings for Syracuse so far in 2025. That’s obviously a small sample but he has six strikeouts to just one walk.

His overall minor league track record isn’t huge either. The canceled 2020 season and Tommy John surgery in 2021 both put a dent in his ability to get work in. He only has 64 1/3 innings of official minor league work from 2022 to 2025, with a 3.92 ERA, 25.7% strikeout rate and 9.1% walk rate. He still has an option and can be sent back to Syracuse without being exposed to waivers if the Mets want to keep him on the 40-man as depth.

Player Option/Opt-Out Update: April Edition

By Steve Adams | April 18, 2025 at 11:58pm CDT

The increasing popularity of opt-outs/player options as a means to close the gap in free agent signings and extensions has changed the face of free agency entirely. Not long ago, opt-outs were perks reserved for the game’s truly elite stars — a benefit to help differentiate nine-figure offers and secure the game’s top stars.

In 2025, they’re downright commonplace. Opt-out laden short-term deals have become a common alternative to the more conventional one-year pillow contract that a player in search of a rebound campaign might pursue. They’ll also provide a soft landing for a veteran whose market didn’t materialize as expected, even coming off a productive season. Some teams simply use them as a means of sweetening the pot even when negotiating with mid- and lower-tier free agents. The Royals gave opt-outs/player options to both Chris Stratton and Hunter Renfroe two offseasons ago. The Reds did the same with Emilio Pagan and Nick Martinez. Tucker Barnhart, Trey Mancini and Ross Stripling are just a few of the other recent examples of solid but non-star veterans to land such clauses in their free agent contracts.

At their core, opt-out provisions aren’t particularly different from club options that have been widely accepted as commonplace for decades. Teams guarantee a certain number of dollars over a certain number of years, and if the player continues performing at a high enough level, they’ll exercise a club option that’s typically locked in at a below-market price. If not, the player will be bought out and sent back to free agency. Player options and opt-outs are merely the inverse; the player/agent negotiate a certain length and annual value but reserve the right to opt back into the market if the player continues to perform at a high level. It’s two sides of the same coin, one favoring the team and the other favoring the player.

There are 16 players around the league this year who’ll have the right to opt into free agency at season’s end, depending on their performance. (Conversely, there are 27 players with club options.) We’ll periodically take a look at this group over the course of the season, as their performances will have a major impact on the 2025-26 market. For more context, you can check out our full list of 2025-26 MLB free agents as well as the first installment of our recent 2025-26 MLB Free Agent Power Rankings, wherein we rank the top 10 free agents in terms of earning power. Darragh McDonald, Anthony Franco and I recently discussed the decision process behind those rankings in the latest episode of the MLB Trade Rumors Podcast.

Onto this year’s group!

Pete Alonso, 1B, Mets | One year, $24MM remaining

Alonso looked like a good bet to opt out from the moment he agreed to terms on his front-loaded two-year, $54MM contract. That he’s been one of the best hitters on the planet in the season’s first three weeks only improves that likelihood. The 30-year-old slugger is slashing a comical .365/.474/.730 with five homers, eight doubles and more walks (12) than strikeouts (10) through his first 78 turns at the plate. Alonso is chasing pitches off the plate at a career-low 19.1% rate and is sporting the best contact rate of his career at 82.8%. He’s doing all of that with career-best marks in average exit velocity (96.3 mph), barrel rate (24.1%) and hard-hit rate (61.1%). Alonso has been an absolute monster, and the fact that he can’t receive a qualifying offer — players can only receive one in their career, and he rejected one last November — is a cherry on top of his dominant output.

Cody Bellinger, OF/1B, Yankees | One year, $25MM remaining (Bellinger receives $5MM buyout if he opts out)

Bellinger posted All-Star numbers with the 2023 Cubs, signed back for three years with a pair of opt-outs and hit well in 2024 — just not to his 2023 standard. Traded to the Yankees this past offseason, many thought he was primed for a rebound because of the favorable dimensions at Yankee Stadium. It hasn’t played out that way. Through his first 62 plate appearances, Bellinger looks more like the lost version of himself from 2021-22 than the strong performer we saw in ’23-’24. He’s hitting .185/.242/.296 with what would be career-worst strikeout and swinging-strike rates of 29% and 15.2%, respectively. When he’s made contact, it’s been loud (90.8 mph average exit velocity, 53.5% hard-hit rate) — and there’s still plenty of time to turn things around. It’s not the start he or the Yankees hoped for, however.

Shane Bieber, RHP, Guardians | One year, $16MM remaining (Bieber receives $4MM buyout if he opts out)

Bieber has yet to pitch this season as he rehabs from last year’s Tommy John surgery. Cleveland has yet to place him on the 60-day injured list, which could offer some optimism regarding his timetable for a return, but he’s not on a minor league rehab assignment yet. At last check, he was targeting a return around the All-Star break.

Alex Bregman, 3B, Red Sox | Two years, $80MM remaining (Bregman can opt out again after 2026)

Bregman has started his Boston tenure on a tear, hitting .321/.365/.564 with four big flies in 85 plate appearances. He’s been 62% better than average, by measure of wRC+, but there are still some of the same red flags he displayed early in the 2024 season. During his peak, Bregman was one of the sport’s toughest strikeouts and showed outstanding plate discipline. From 2018-23, he walked in 13.8% of his plate appearances against a puny 12.3% strikeout rate. Bregman’s walk rate fell off a cliff last season, and it hasn’t recovered so far in 2024. He’s drawn only four free passes (4.7%). More concerning, he’s fanned 18 times, leading to what would be a career-worst 21.2% strikeout rate. Bregman’s chase rate is down, and he’s still making elite contact within the strike zone, but he’s making contact on a career-low 56.5% of his swings on balls off the plate. If he keeps hitting like this, it probably won’t matter, but it’s something to watch as the season continues.

Edwin Diaz, RHP, Mets | Two years, $37MM remaining (Diaz can opt out again after 2026)

Diaz had a nice return from a 2023 season lost to a knee injury in 2024, pitching to a 3.52 ERA with a 38.9% strikeout rate against a 9.3% walk rate. It wasn’t quite his usual level of dominance, but most relievers would happily take a 39% punchout rate in a “down” season. Things aren’t going as well in 2025. Diaz’s four-seamer is sitting at a career-low 96.4 mph, per Statcast. That’s down 1.1 mph from last year’s mark and 2.5 mph from his 99.1 mph peak in 2022. If he were still overpowering opponents, it wouldn’t matter much, but Diaz has been tagged for five runs on six hits and five walks in 6 2/3 frames. That’s a 16% walk rate, and he’s already tossed four wild pitches — more than he did in 53 2/3 innings a year ago. The caveat with everyone on this list is that we’re all of 11-12% through the season, but the early trendlines aren’t good for Diaz.

Jack Flaherty, RHP, Tigers | One year, $10MM remaining (increases to $20MM once Flaherty makes 15 starts)

Flaherty’s heater is down nearly a mile per hour, and his walk rate is up from 5.9% to 10.3% … but that’s in a span of 21 1/3 innings. He’s still getting strikeouts at a plus level (28.7%), and the bottom-line results are good: 2.53 ERA. Flaherty seems healthy, which will be a big factor for him — both in terms of boosting his stock ahead of a potential return to free agency and in boosting his 2026 salary if he winds up forgoing the opt-out opportunity. If he can deliver a third straight season of 27-plus starts and a second straight year with a plus strikeout rate and low-3.00s (or even mid-3.00s) ERA, the market will likely reward him with the long-term deal that eluded him this past winter. Flaherty doesn’t turn 30 until October. He’ll have a chance at a deal ranging from four to six years in length if he comes close to replicating his 2024 performance. One potential downside: he was traded last summer and thus ineligible to receive a qualifying offer. If the Tigers contend all season, as expected, they’ll be able to make Flaherty a QO if he opts out.

Lourdes Gurriel Jr., OF, D-backs | One year, $18MM remaining

Though he’s one of the most consistent hitters in the sport, Gurriel is out to a woeful start in 2025. His D-backs are red-hot, but their current win streak comes in spite of an anemic .145/.176/.304 start from their everyday left fielder. Gurriel has some of the best contact skills in MLB, fanning in only 17.3% of his plate appearances and making contact on just shy of 90% of his swings in the zone dating back to 2022. He’s punched out in what would be a career-low 13.5% of his plate appearances this year, but he’s staring down a .121 average on balls in play. He should be due for a course correction, but it’s worth noting that he’s hitting more fly-balls and fewer line-drives than ever, which is going to naturally suppress his BABIP a bit (although certainly not to this extent). Gurriel is owed $13MM in 2026 and has a $5MM buyout on a $14MM club option for 2027. He’d need to be confident he could top not just $18MM but probably that he’d top two years and $27MM; the hefty nature of that buyout makes him a net $9MM decision for the D-backs in 2027, which seems like a price they’ll be willing to pay.

Ha-Seong Kim, SS, Rays | One year, $16MM remaining

Kim is still finishing up the rehab from last October’s shoulder surgery. He’s expected back mid-to-late May, which would give him about four months to prove he’s back to form. A healthy Kim would’ve been a coveted free agent who could’ve commanded four or more years in free agency. A plus defender at three positions and a plus runner with enough power to pop 10 to 20 homers annually, Kim will be in high demand next offseason if the shoulder injury doesn’t prove a major drain on his offensive capabilities.

Seth Lugo, RHP, Royals | One year, $15MM remaining

Lugo’s rise from reliever to starter to Cy Young finalist has been remarkable. He’s gotten decent results in 2025, with a 3.86 ERA in his first 23 1/3 innings, but his strikeout and walk rates are nowhere near last year’s marks. After fanning 21.7% of his opponents against a pristine 5.7% mark last year, the 35-year-old Lugo currently sports respective rates of 17% and 9.6%. His velocity is below par (92.2 mph average fastball) but right in line with last year’s levels. A year and $15MM should be the floor for a healthy Lugo, even if he doesn’t repeat his brilliant 2024 season. That’s the same mark that older starters like Charlie Morton, Justin Verlander, Alex Cobb and Max Scherzer (well, $15.5MM) received this past offseason. The Royals could tag him with a qualifying offer if he opts out, which would give him a tougher call on a one-year deal that should be worth more than $21MM. That said, if Lugo comes anywhere close to last year’s results, he’d turn that down in pursuit of a multi-year deal.

A.J. Minter, LHP, Mets | One year, $11MM remaining

Minter’s 94.3 mph average fastball is a career-low, but it’s only narrowly shy of his 2024 mark (94.5 mph). It’s feasible that as he further distances himself from last year’s hip surgery, that number could tick up, too. He’s pitched 8 1/3 innings, allowed a pair of runs on five hits and a walk, and punched out a dozen hitters. That’s a whopping 38.7% strikeout rate. So far, Minter is missing more bats within the strike zone than ever before; opponents have an awful 73% contact rate on his pitches in the zone (compared to the 85% league average). Minter landed two years and $22MM with an opt-out when he was coming off hip surgery. He should be able to top a year and $11MM so long as he’s healthy and pitches to his typical levels. So far, so good.

Frankie Montas, RHP, Mets | One year, $17MM remaining

Montas has yet to pitch in 2025 after suffering a lat strain during spring training. He’s yet to begin a minor league rehab stint but, like Bieber, also has not been placed on the 60-day injured list yet. The size of the Mets’ commitment to Montas this winter registered as a bit of a surprise even when he was thought to be healthy. He’ll need a strong few months to walk away from $17MM guaranteed.

Tyler O’Neill, OF, Orioles | Two years, $33MM remaining

The biggest question with O’Neill is whether he can stay healthy enough to position himself for an opt-out. He’s mashing with a .265/.339/.490 slash and two homers through 56 plate appearances. (One of those big flies extended his ludicrous MLB record of six straight Opening Days with a long ball.) He’s also missed the past couple games due to neck discomfort. O’Neill has never played in more than 138 games in a season, and he’s only twice reached 100 games in a year. (He did play 50 of 60 games in the shortened 2020 season.) O’Neill’s 21.4% strikeout rate would be a career-low, but his actual contact rate and swinging-strike rate aren’t career-best marks. It’s hard to see him sustaining that career-low strikeout rate as a result, but O’Neill’s power is substantial enough that he can be a productive hitter even running strikeout rates approaching/exceeding 30%.

Joc Pederson, DH/OF, Rangers | One year, $18.5MM remaining (Rangers can counter opt-out by exercising 2027 club option for $18.5MM)

Signed to help the Rangers remedy their 2024 ineptitude against fastballs, Pederson has instead turned in a career-worst performance against heaters (and every other offering). It’s only 16 games, but Pederson has collected just one hit against fastballs in 2025 — a single. It’s an alarming development for a hitter who carries a lifetime .244 average and .521 slugging percentage against four-seamers. Pederson has compiled an unfathomable .060/.161/.080 slash in 57 plate appearances. He’s still making a fair bit of hard contact, but most of it is resulting in grounders. His 55.6% ground-ball rate and 2.8% (!) line-drive rates are career-worst marks. There’s no earthly way he can continue to struggle this much, but he’ll need quite the turnaround for that opt-out provision to come into play.

Wandy Peralta, LHP, Padres | Two years, $8.9MM remaining (Peralta can opt out again after 2026)

Peralta posted a career-worst 13.6% strikeout rate in year one of his four-year pact with San Diego in 2024. He passed on his first opt-out opportunity, and understandably so. It’s early, but the veteran lefty has more than doubled last year’s awful 8.3% swinging-strike rate, which now sits at 16.8% through 8 1/3 innings. Peralta is generating chases on an eye-popping 40% of his pitches off the plate, and his opponents’ 44.4% contact rate on those swings is the second-best mark of his career. He’s all but shelved his four-seamer, is barely using his slider, and is leaning hard into a sinker/changeup combo. He won’t sustain a 1.08 ERA, of course, but if he keeps piling up grounders and whiffs, he’ll have a good case to opt out, even at age 34.

Trevor Story, SS, Red Sox | Two years, $55MM remaining

It’s hard to believe we’re already in year four of Story’s six-year deal with Boston — in part because we simply haven’t seen him in a Red Sox uniform all that often. The former Rockies All-Star played in only one-third of the team’s games through the first three years of the contract. Injuries have decimated Story in recent years, and he produced a middling .232/.296/.397 line when healthy enough to play from 2022-24. He’s out to a much better start in 2025, playing in 20 games (already just six shy of last year’s total) and recording a .299/.325/.442 line with three homers. A 3.8% walk rate, 30% strikeout rate and .400 BABIP through 80 plate appearances don’t bode especially well, but to his credit, Story is torching the ball; he’s averaging 90.3 mph off the bat and has even better marks in barrel rate (11.3%) and hard-hit rate (54.7%). It’s hard to see him turning down the two years and $55MM after he’s been injured so much in Boston, but he’s enjoying a fine start to the year.

Robert Suarez, RHP, Padres | Two years, $16MM remaining

Suarez’s name popped up late in the offseason rumor mill, but he was always going to be a tough trade candidate because of this two-year player option. If he performed well, he’d opt out, and if he struggled and/or got hurt, the acquiring team would be saddled with two unwanted years. Such is the nature of trading anyone with a player option/opt-out. Suarez stayed put, and the Padres have to be thrilled. He’s 8-for-8 in save opportunities, hasn’t allowed a run in nine innings, and is boasting a 31.3% strikeout rate against a 6.3% walk rate. That strikeout rate is supported by a huge 16% swinging-strike rate. Suarez looks unhittable right now, just as he has in the past when at his best. There’s a lot of season left, and things can go south in a hurry for relievers in particular, but a player couldn’t ask for a better start to a platform season.

Mets Not Planning To Add A Starter

By Steve Adams | February 21, 2025 at 10:10am CDT

The Mets’ rotation suffered a blow barely a week into camp when free agent acquisition Frankie Montas felt discomfort in his first bullpen session of camp. After a healthy offseason, Montas was diagnosed with a lat strain that has prompted the Mets to shut him down from throwing entirely. The team announced a no-throw period of six to eight weeks. Montas is taking a more optimistic tack, suggesting it’ll be four to six weeks. Regardless, he won’t throw at all for the majority of spring training, at which point he’ll need to build up from scratch. An absence extending into at least mid-May seems likely.

Even with that loss and a handful of notable starters still on the market, the Mets aren’t planning to add another arm to their rotation, Will Sammon of The Athletic reports. While further injuries could of course change that thinking, for now the Mets plan to rely on their in-house depth while weathering their first injury of note. Additionally, the previously planned six-man rotation will now likely drop to five, manager Carlos Mendoza tells Joel Sherman of the New York Post.

Locks for the Opening Day rotation, health permitting, include Kodai Senga, Sean Manaea, David Peterson and reliever-turned-starter Clay Holmes. Righties Tylor Megill, Griffin Canning and Paul Blackburn will vie for the fifth spot. Megill has a minor league option remaining. Canning and Blackburn do not, and both are earning more than $4MM this season, so it’s unlikely they’d be cut loose. (That’s especially true of Canning, who signed as a free agent over the winter.) Top prospect Brandon Sproat will be in the running at some point, but he still has only 116 1/3 professional innings under his belt, with only 28 2/3 of those coming in Triple-A.

Sammon’s report dovetails with recent suggestions that the Mets aren’t likely to pursue a reunion with Jose Quintana, despite the veteran left-hander’s openness to returning to Queens. Quintana declined an offer worth more than $5.25MM from the Pirates before Pittsburgh agreed to terms with fellow left-handed veteran Andrew Heaney. While it’s not clear that decision was made in hopes of the Mets coming through with an offer of their own, it does appear to shut the door on opportunities for Quintana with either club. Beyond Quintana, veterans like Kyle Gibson, Lance Lynn and Spencer Turnbull are all still seeking homes.

For the Mets, any additions to the major league roster will be doubly cost prohibitive. They’re again a CBT payor in the top penalty tier, meaning any subsequent additions come with a 110% luxury tax. Signing Quintana in the $5-6MM range, for instance, would cost the team $10.5MM to $12.6MM. The Mets are already running a $331MM cash payroll, per RosterResource, which comes with nearly $67MM worth of luxury taxes.

In essence, the Mets are already paying close to $400MM total for the current roster. On the one hand, fans could argue “what’s another $10-12MM at that point?” On the other, even the sport’s wealthiest owner, Steve Cohen, surely has his limits. Plus, if things go according to plan in 2025, the Mets will be deadline buyers, presumably adding even further to that massive financial outlay. Time will tell whether the rest of the rotation group holds up through the remainder of camp — injuries abound in spring training every year — but for now, Mets fans shouldn’t hold out hope for a Quintana reunion or any other guaranteed deal to deepen the starting staff.

NL East Notes: Sale, Montas, Wood

By Darragh McDonald | February 19, 2025 at 2:36pm CDT

Braves left-hander Chris Sale just had a tremendous bounceback season. He made 29 starts with a 2.38 earned run average, earning a National League Cy Young award. He was largely injured and/or ineffective from 2019 to 2023, which had him pondering retirement.

“I thought that it was gonna be my last year,” Sale said to the Baseball Isn’t Boring podcast about where he was at before getting traded to Atlanta. “So I went into that offseason on a mission like ’one more year left.’… ’cause in my mind, I wasn’t walking away from baseball. I was walking away from getting hurt.”

The Red Sox traded Sale to Atlanta for Vaughn Grissom in December of 2023. At the time, as mentioned, he had been battling significant injuries for five years. Tommy John surgery in 2020 was the big one but Sale also had a stress reaction in his ribs, a fractured finger, a broken wrist suffered in a bicycle accident and a stress reaction in his shoulder blade over that span. He had a 4.16 ERA in 298 1/3 innings over those five seasons.

2024 was the final year of his extension with the Red Sox and the mounting injuries apparently had him looking towards hanging up his spikes. But he was traded to Atlanta, signed an extension that covered 2024 and 2025 with a club option for 2026, and then went on to have an excellent season in 2024. It makes for an interesting “what if” but Sale is clearly in a better spot now. The injury bug hasn’t left him entirely alone, however. He missed the final two weeks of 2024 due to back spasms and was also left off Atlanta’s postseason roster. 2024 was still a big improvement over prior years but time will tell if he can keep the good health going into his age-36 season.

Some more spring training tidbits from the NL East…

It was reported earlier this week that Mets righty Frankie Montas has a lat strain and will be shut down for six to eight weeks. The righty is apparently a bit more optimistic than his club, however. He told members of the media today, including Anthony DiComo of MLB.com, that he’s already feeling better from his platelet-rich plasma injection and expects to be throwing again in four to six weeks. That’s still a notable period of time but it’s a bit less dire than the other timeline. He had a 4.84 ERA last year and then signed a two-year, $34MM deal with the Mets this winter. He will have the chance to opt out after the first year, though returning healthy and productive will be important if he is to consider that possibility. For now, the Mets’ rotation mix includes Sean Manaea, Kodai Senga, David Peterson, Clay Holmes, Paul Blackburn, Griffin Canning and Tylor Megill.
Nationals outfielder James Wood has some quad tendinitis, per Andrew Golden of The Washington Post. It doesn’t bother him when he hits, so he’s been able to take batting practice but has skipped some defensive drills. Per Mark Zuckerman of MASNsports.com, Wood says he has “zero” concern but the club did send him for an MRI, which showed no structural damage. With still over a month before Opening Day, there’s plenty of time to get things in order, with Wood and the Nats both surely hoping for a clean bill of health by then. Now just 22 years old, Wood hit .264/.354/.427 in his major league debut last year and is slated to be a big part of the club’s future.

Load More Posts

Show all

Headlines

Frankie Montas

Navigation

MLBTR INFO

Connect